retatrutide clinical trials news Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 trials, is being sold openly across the internet and prescribed by licensed physicians online and This has quietly been a

Patients with certain GIPR or GLP1R profiles often respond better to tirzepatide or dual-therapy combinations, while others maximize results with semaglutide alone

Healthcare providers should know that an allergic reaction is possible if an individual is sensitive to cobalt

Our researchers were delighted to get caught up with many friends including GBDS Project Manager Patricia E

The unique structural properties of S-Phenylacetyl Glutathione enable it to bypass typical glutathione degradation pathways that occur in extracellular environments

Williamson RL, McCarthy EA, Oats JJ, Churilov L, Lappas M, Shub A (2021) Obstetric and perinatal outcomes for women with pre-existing diabetes in rural compared to metropolitan settings in Victoria, Australia